ORAI3 and prostate carcinoma: Interestingly, in breast and lung cancer cells, Orai3 was demonstrated to encode a homomeric SOCE channel whereas in prostate cancer cells Orai3 was shown to constitute a heteromeric ARC channel [25,32,40].